Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2009
07/08/2009CN100509812C Process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
07/08/2009CN100509811C Azaindoles
07/08/2009CN100509810C Substituted beta-carbolines
07/08/2009CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
07/08/2009CN100509804C N-substituted piperidine derivatives as serotonin receptor agents
07/08/2009CN100509801C HIV inhibiting pyrimidines derivatives
07/08/2009CN100509797C Thiophene derivatives used as antiviral agent against flavivirus infections
07/08/2009CN100509794C Therapeutic heterocyclic compounds
07/08/2009CN100509791C Compound and use of the compound as glycine transport inhibitors
07/08/2009CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
07/08/2009CN100509789C Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
07/08/2009CN100509788C Neurotensin active 2,3-diaryl-pyrazolidine derivatives
07/08/2009CN100509784C Inhibitors of hepatitis C virus ns3/ns4a serine protease
07/08/2009CN100509783C Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
07/08/2009CN100509782C NK* antagonists
07/08/2009CN100509781C Method for producing 1,4-diphenyl azetidinone derivatives
07/08/2009CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase
07/08/2009CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives
07/08/2009CN100509758C Crystal of triterpene derivative
07/08/2009CN100509058C Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
07/08/2009CN100509027C Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil
07/08/2009CN100509015C Combination of medication for treating gastric ulcer
07/08/2009CN100508990C Acrochordon alleviation
07/08/2009CN100508987C Application of hyaluronate in preparing oral products used for preventing or improving ocular vitreous degeneration disease
07/08/2009CN100508986C Antineoplastic baicalein and baicalin synergistic pharmaceutical composition
07/08/2009CN100508985C Algin oligose and derivative thereof and producing method and use thereof
07/08/2009CN100508984C Vitamin composition used for marine product
07/08/2009CN100508983C Methylprednisolone sodium succinate lyophilized composition and preparing method thereof
07/08/2009CN100508982C Medicinal composition containing ceftriaxone sodium and lidocaine hydrochloride injection
07/08/2009CN100508981C Pharmaceutical composition of piperazine derivatives
07/08/2009CN100508980C Compositions for combating lower urinary tract dysfunctions with delta opioid receptor agonists
07/08/2009CN100508979C Use of tetrandrine as chemotherapy pharmaceutical sensitivity agent for treating gastric cancer
07/08/2009CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
07/08/2009CN100508977C Slow release tablet of medetofazone
07/08/2009CN100508976C Orally dissolving films
07/08/2009CN100508975C Use of pyrazolopyridine compound
07/08/2009CN100508974C Transdermal patch for administering fentanyl
07/08/2009CN100508973C Maleic acid levo amido chloro diping oral disintegration tablet and preparation method thereof
07/08/2009CN100508972C Mutamycine C multivesicular liposome and preparing method thereof
07/08/2009CN100508971C Medicine composition possessing vasodilation and beta1 receptor blocking effects
07/08/2009CN100508970C Baicalin solution composition
07/08/2009CN100508969C Nano particles of taxane cyclodextrin inclusion compound and preparation method thereof
07/08/2009CN100508968C Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
07/08/2009CN100508967C Taurine and anti-infectious medicine composition
07/08/2009CN100508966C Pharmaceutical preparation containing gabapentin
07/08/2009CN100508965C Dosage forms having prolonged active ingredient release
07/08/2009CN100508964C Patch
07/08/2009CN100508963C Antimicrobial compositions
07/08/2009CN100508962C The use of kauranes compounds in the preparation of medicament
07/08/2009CN100508961C Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy, and the pharmaceutical use thereof
07/08/2009CN100508768C Ubiquinol-enriched fat-containing foods
07/07/2009USRE40839 Taxol treatment of cancer
07/07/2009USRE40838 modulators of opioid receptors; irritable bowel syndrome, drug addiction, including alcohol addiction, depression, anxiety, schizophrenia, eating disorders
07/07/2009USRE40837 Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent
07/07/2009US7557247 N-{2-[4-((R)-2-hydroxy-2-phenylethylamino)phenyl]ethyl}-(R)-2-hydroxy-2-(3-formamido-4-hydroxyphenyl)ethylamine monohydrochloride; pulmonary disease asthma or chronic obstructive pulmonary disease; administration by inhalation; salt formation, crystallization
07/07/2009US7557236 reacting hydrogen sulfide with epoxidized vegetable oils, in the presence of catalysts, to form mercaptohydroxy vegetable oils; chemical intermediates for polythiourethanes used in fertilizers coatings
07/07/2009US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis
07/07/2009US7557221 Substituted hydantoins
07/07/2009US7557219 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
07/07/2009US7557213 Such as 3-(Pyridine-4-carbonyl)-1-pyridin-2-ylmethyl-H-quinolin-4-one for treatment of cancer
07/07/2009US7557210 Antiinflamamtory agents
07/07/2009US7557183 Polyethylene glycol linked GLP-1 compounds
07/07/2009US7557146 Method of preparing lycopene-enriched formulations that are free of organic solvents, formulations thus obtained, compositions comprising said formulations and use of same
07/07/2009US7557145 For use in filter media, adhesives, building materials, building auxiliaries, textiles, pelts, paper, skins or leather, laundry detergents, cleaning compositions, rinse agents, hand washing preparations, manual dishwashing detergents, machine dishwashing detergents
07/07/2009US7557144 Cystic fibrosis transmembrane conductance regulator genes/proteins; transmembrane proteins
07/07/2009US7557143 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones
07/07/2009US7557142 Administering otoprotective agent comprising methionine or derivative to patient undergoing chemotherapy; side effect reduction
07/07/2009US7557141 Method of treating autoimmune diseases
07/07/2009US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis
07/07/2009US7557139 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
07/07/2009US7557138 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel
07/07/2009US7557137 Gamma-lactams as beta-secretase inhibitors
07/07/2009US7557136 Pyrrolidine derivatives as oxytocin antagonists
07/07/2009US7557135 Inhibitors of cytosolic phospholipase A2
07/07/2009US7557134 Transient receptor potential vanilloid (capsaicin receptor) antagonist or agonist; analgesics; treating chronic inflammatory pain, neuropathic pain, migraine and acute pain; bladder hyperactivity, hyperreflexia, or instability; incontinence, urgent urination, cystitis; antiasthmatics, antitussives
07/07/2009US7557133 Such as (3S)-5-[(2,6-dichlorobenzoyl)oxy]-3-({[5-methyl-3-phenyl-4,5-dihydro-5-isoxazolyl]carbonyl}amino)-4-oxopentanoic acid for preventing inflammation and apoptosis; crystallization
07/07/2009US7557132 Compounds useful as pesticides
07/07/2009US7557131 Substituted triazole derivatives as oxytocin antagonists
07/07/2009US7557130 Bicyclic heteroaromatic alanines
07/07/2009US7557129 Cyanopyridine derivatives useful in the treatment of cancer and other disorders
07/07/2009US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen
07/07/2009US7557127 HDAC inhibitor
07/07/2009US7557126 Diphenylmethyl compounds useful as muscarinic receptor antagonists
07/07/2009US7557125 Fab I inhibitors
07/07/2009US7557124 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
07/07/2009US7557123 Heterocyclic compound and medicinal use thereof
07/07/2009US7557122 Pyrrolopyridine compounds, method of making them and uses thereof
07/07/2009US7557121 Tetrahydronaphthyridine derivatives
07/07/2009US7557120 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
07/07/2009US7557119 analgesics, antidiarrheal agents, anticonvulsants, antitussives, anti-addiction; 8-Substituted-2,6-methano-3-benzazocines
07/07/2009US7557118 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators
07/07/2009US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives
07/07/2009US7557116 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1H-pyrano[2,3d 6,5-d′]dipyrimidyne and 10-aza-analogue thereof
07/07/2009US7557115 Compounds for modulation of kinesins as anticancer agents with administering
07/07/2009US7557114 Heterocyclic-substituted phenyl methanones
07/07/2009US7557113 5-{2-[(t-butoxy)carbonylamino]ethyl}-6-{3-chloro(2-thienyl)}-4-oxo-3-hydr- opyrrolo[3,2-d]pyrimidin-7-carboxyamide; GSK-3 inhibitor; diabetes, diabetic complications, Alzheimer's, neurodegenerative, manic depression, traumatic cerebrospinal injury, alopecia, inflammatory diseases, cancer, immunodeficienc
07/07/2009US7557112 Aromatic-ring-fused pyrimidine derivative
07/07/2009US7557111 {1-[7-(4-bromo-2,6-dimethyl-phenyl)-2-methyl-thieno[3,2-d]pyrimidin-4-yl]-piperidin-4-yl}-methanol; depression, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastral diseases, drug dependence, epilepsy, cerebral, inflammation, immunity, sleep, IBS, alopecia
07/07/2009US7557110 Pyrazolo[1,5-A] pyrimidine derivatives
07/07/2009US7557109 Eltoprazine;